CYTK   $61.7  -1.99% Market Closed After Close 61.7 0.0

Cytokinetics, Incorporated
Total Cash 1.06B
totalCashPerShare 8.982
EBITDA -493.16M
Total Debt 790.18M
quickRatio 10.282
currentRatio 10.39
Total Revenue 3.13M
debtToEquity 727.937
Revenue/Share 0.031
ROA -0.27461
ROE
grossProfits
freeCashflow -233.93M
operatingCashflow -399.06M
earningsGrowth
revenueGrowth -0.713
grossMargins 0.0
ebitdaMargins 0.0
operatingMargins -522.7791
profitMargins 0.0
enterpriseValue 6.26B
forwardPE -11.303463
floatShares 117.06M
sharesOutstanding 117.66M
sharesShort 15.54M
sharesShortPriorMonth 17.84M
dateShortInterest
sharesPercentSharesOut 0.13%
heldPercentInsiders 0.01%
heldPercentInstitutions 1.18%
Short Ratio help_outline 12.11%
shortPercentOfFloat 0.20%
impliedSharesOutstanding
bookValue 0.924
Price To Book help_outline 60.06
earningsQuarterlyGrowth
netIncomeToCommon -545.28M
trailingEps -5.36%
forwardEps -4.97%
enterpriseToEbitda -12.70
lastDividendValue
lastDividendDate
currentQuarterEstimate -1.25 3Q 2024
institutionsCount 473
lastUpdated Nov. 7, 2024, 9:24 a.m.